QBR112103 (VX11-765-007)

• Research type

  Research Study

• Full title

  A Phase 1, Open Label, Randomized, Single and Multiple Dose, Partial Crossover Study to Investigate the Relative Bioavailability of Immediate Release and Modified Release Formulations of VX 765 in Healthy Adult Subjects

• IRAS ID

  87528

• Contact name

  Sharan Sidhu

• Contact email

  sharan.sidhu@quotientclinical.com

• Sponsor organisation

  Vertex Pharmaceuticals Incorporated

• Eudract number

  2011-002958-30

• Research summary

  Research Summary not published at request of researcher

• REC name

  North West - Greater Manchester Central Research Ethics Committee

• REC reference

  11/IE/0135

• Date of REC Opinion

  27 Sep 2011

• REC opinion

  Further Information Favourable Opinion